Results in this study demonstrated that silencing lncRNA FOXD2-AS1 inhibited migration, invasion, proliferation and drug resistance of drug-resistant glioma cells and promoted their apoptosis via enhancing the expression of miR-98-5p or decreasing CPEB4. Here, FOXD2 is linked to central nervous system cancer.